Cite
HARVARD Citation
Jiang, X. et al. (2022). A randomized, open‐label, two‐period crossover bridging study on fuzuloparib capsules of different specifications in healthy Chinese volunteers. British journal of clinical pharmacology. 88 (3), pp. 1087-1093. [Online].